Semperit Ag Holding · VIE:SEM
Semperit — Investor Presentation (January 2020)
18 slides from Semperit's investor presentation, Jan 30, 2020
Slide 1: Future Strategy: Focus on industrial rubber, separation from medical business
SEMPERIT GROUP FUTURE STRATEGY: Focus on industrial rubber, Separation from medical business Dr Martin Füllenbach, CEO Frank Gumbinger, CFO 30 January 2020 1
Slide 2: Agenda
Agenda 1. Towards market orientation 2. Changing Business Model 3. New Financial Framework 4. New Financial Targets 5. New Investment Proposition 2 Investor Presentation Future Strategy I 30 January 2020 I Investor Relations
Slide 3: Higher market and customer orientation
Higher market and customer orientation New industrial rubber strategy with focus on regional and application-related customer intimacy Industry only New COO for Industrial core business with strong industry specific background Separation from the medical segment decided 5% CAGR Organic growt
Slide 4: 1st key initiatives
1st key initiatives New industrial rubber strategy with focus on regional and application-related customer intimacy New COO for Industrial core business appointed in charge of Semperit Lean Programme, supply chain management and Mixing business Separation from the medical segment decided Set
Slide 5: Agenda
Agenda 1. Towards market orientation 2. Changing Business Model 3. New Financial Framework 4. New Financial Targets 5. New Investment Proposition 5 Investor Presentation Future Strategy I 30 January 2020 I Investor Relations
Slide 6: Leveraging new growth opportunities – Semper Growth200
Leveraging new growth opportunities –Semper Growth200 Low coverage of regions and • Diversify portfolio geographically with first industries focal point on North America Competition predominantly by (product-) cost positioning • Product and customer centric focus • Digitization and innovation Strong
Slide 7: Industry sector heavily exposed to the European market
Example: The portfolio of the industry sector is heavily exposed to the European market with ~75% of total revenues in 2018 Semperit Industrial Sector – Segment Revenues by Region [EUR mn, 2018] 145 230 192 567 1% 1% • Throughout the businesses, EMEA 6% 5% 2% 100% 10% 8% and especially Western Europ
Slide 8: Agenda
Agenda 1. Towards market orientation 2. Changing Business Model 3. New Financial Framework 4. New Financial Targets 5. New Investment Proposition 8 Investor Presentation Future Strategy I 30 January 2020 I Investor Relations
Slide 9: Principles of financial policy
Principles of financial policy Stringent value management and cash generation KEY KPIs: FOCUS: top-line growth, Sales growth, profitability, EBITDA margin, cash and returns FCF, ROCE PRINCIPLES: portfolio upgrade, platform leverage, operational excellence, financial discipline, capital efficiency, r
Slide 10: Mid-term capital allocation priorities
Mid-term Capital allocation priorities Organic growth Balance sheet management Future dividend commitment (50% of positive net result) Bolt-on acquisitions (contingent on Sempermed sale) Mid-term ROCE target: ~10% 10 Investor Presentation Future Strategy I 30 January 2020 I Investor Relations
Slide 11: New financial policy framework
New financial policy framework Based on the new Industrial structure % € € € 5% CAGR Group EBITDA margin Free Cash Flow ROCE ~10% top-line growth ~13% positive t+1 following (by end of 2024) (by end of 2024) sale of Sempermed € € Equity ratio >30% Net debt / EBITDA Working capital to Cost at Corpora
Slide 12: Sempermove10 shows material impact: consistent yoy EBITDA improvement
Sempermove10 shows material impact: Consistent yoy EBITDA improvement for 7th consecutive quarter 22.7 10.1% 17.0 17.3 15.8 16.5 7.5% 8.0% 7.7% 13.1 7.1% 5.9% 4.5 2.2% 1) 2) Q1 Q2 Q3 Q4 EBITDA margin 2018 EBITDA margin 2019 EBITDA, in EURm 2018 EBITDA, in EURm 2019 Positive development of profitab
Slide 13: Cash flow development
Cash flow development Improved results, active WC management and strict CAPEX control support cashflow development First positive free cash flow after negative previous years Development of cash flow components1) in € m 83 50 60 34 15 -9 -21 -42 -23 -43 -57 -71 Q1-3 2016 Q1-3 2017 2) Q1-3 2018 Q
Slide 14: Financial profile and covenants
Financial profile and covenants Equity ratio of 39.7% as of 30 September 2019 (Covenant: >30%) Net debt / EBITDA of 1.1 times (Covenant: <3.5x) Hybrid capital of €130m strengthens equity, additional option to draw remaining 20 mn strengthened equity being a perpetual, review exercise of call optio
Slide 15: Agenda
Agenda 1. Towards market orientation 2. Changing Business Model 3. New Financial Framework 4. New Financial Targets 5. New Investment Proposition 15 Investor Presentation Future Strategy I 30 January 2020 I Investor Relations
Slide 16: New financial targets with focus on industrial rubber
New financial targets with focus on industrial rubber Ø 2017 – Q1-3’19 2024 Sales 0% 5% CAGR top-line annual growth1) EBITDA Margin adj. 5.9% Group EBITDA margin move to ~13% ’16 – ’18: negative2) Free Cash Flow positive t+1 following sale of Sempermed ’19: positive ROCE – ROCE ~10% Equity ratio 38%
Slide 17: Agenda
Agenda 1. Towards market orientation 2. Changing Business Model 3. New Financial Framework 4. New Financial Targets 5. New Investment Proposition 17 Investor Presentation Future Strategy I 30 January 2020 I Investor Relations
Slide 18: New Investment Proposition
New Investment Proposition Industrial rubber • International diversification with stronger focus on North America specialist leveraging new • Global platform for procurement, supply chain and growth prospects manufacturing excellence • Centralised regional centres with clear focus on profitability …
Semperit AG Holding — Investor Presentation (January 2020) on 6ix